A. O'Reilly

Single dose of BNT162b2 mRNA vaccine against SARS-CoV2 induces neutralizing antibody and polyfunctional T-cell responses in patients with CML

M. Malim, D. Mclornan, C. Graham, 2021, medRxiv.

Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemia

Jeffrey A Jones, J. Byrd, J. Flynn, 2014, mAbs.

Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemia

Jeffrey A Jones, J. Byrd, J. Flynn, 2014, mAbs.